细胞沉默脱靶效应测序检测

原创版权来源：中析研究所发布时间：2025-09-11 01:16:08 咨询量：【大中小】 | 【打印】

承诺：我们的检测流程严格遵循国际标准和规范，确保结果的准确性和可靠性。我们的实验室设施精密完备，配备了最新的仪器设备和领先的分析测试方法。无论是样品采集、样品处理还是数据分析，我们都严格把控每个环节，以确保客户获得真实可信的检测结果。

信息概要

细胞沉默脱靶效应测序检测是一种高通量测序技术，用于评估基因沉默方法（如RNA干扰或CRISPR）在非目标基因上产生的 unintended effects，确保其特异性和安全性。
该检测在基因治疗、药物开发和基础研究中至关重要，因为它能识别和量化脱靶事件，从而减少潜在毒副作用、提高治疗 efficacy，并符合 regulatory requirements。
产品概述：通过深度测序和生物信息学分析，提供全面的脱靶效应评估，包括 off-target site 识别、表达变化分析和功能影响预测，帮助研究人员优化沉默策略。

检测项目

Off-target site identification
Gene expression profiling
Sequence alignment accuracy
Mutation detection rate
Insertion and deletion analysis
RNA secondary structure prediction
Off-target scoring
Gene ontology enrichment
Pathway analysis
Variant calling
Read depth coverage
Quality control metrics
Specificity assessment
Sensitivity calculation
False positive rate
False negative rate
GC content bias
Sequence complexity evaluation
Off-target effect size
Functional impact prediction
Conservation score analysis
Epigenetic modification assessment
Cell viability correlation
Off-target localization
Transcriptome-wide screening
Protein binding site analysis
Non-coding RNA off-targets
Splice variant detection
Allele-specific expression
Cross-species homology check
Off-target persistence over time
Dose-response relationship
Background noise estimation
Statistical significance testing
Multi-omics integration

检测范围

siRNA-based silencing
shRNA-based silencing
CRISPR/Cas9 gene editing
CRISPR/Cas12a systems
CRISPR/Cas13 RNA targeting
Antisense oligonucleotides
RNAi therapeutics
MicroRNA mimics
Small molecule inhibitors
Gene knockout models
Stem cell applications
Cancer cell lines
Primary human cells
Animal models (e.g., mouse, rat)
Plant cell silencing
Viral vector delivery systems
Non-viral delivery methods
In vitro assays
In vivo studies
Clinical samples
High-throughput screening
Single-cell analysis
Tissue-specific silencing
Organoid models
Personalized medicine approaches
Drug discovery platforms
Biomarker validation
Regulatory compliance testing
Academic research projects
Industrial R&D applications
Diagnostic development
Therapeutic efficacy studies
Toxicology assessments
Pharmacogenomics
Functional genomics screens

检测方法

Next-generation sequencing (NGS): High-throughput sequencing to identify off-target sites and expression changes.
Whole transcriptome sequencing: Comprehensive analysis of RNA levels to detect unintended effects.
PCR-based methods: Amplification and quantification of specific regions for validation.
Bioinformatics pipeline: Custom algorithms for data analysis and off-target prediction.
Alignment algorithms: Tools like BWA or Bowtie for mapping sequences to reference genomes.
Variant calling: Identifying mutations and indels from sequencing data.
Expression quantification: Methods like RNA-seq for measuring gene expression.
Statistical analysis: Applying models to assess significance of off-target events.
Machine learning approaches: Predictive modeling for off-target risk assessment.
Quality control procedures: Ensuring data integrity and reproducibility.
Deep sequencing: High-depth coverage for sensitive detection of rare events.
Functional enrichment analysis: Determining biological pathways affected by off-targets.
Cross-validation: Using multiple methods to confirm findings.
Cell-based assays: In vitro tests to measure silencing efficiency and off-target effects.
In silico prediction: Computational tools to forecast potential off-target sites.
Multiplexed assays: High-throughput testing of multiple targets simultaneously.
Real-time PCR: Quantitative measurement of gene expression changes.
Western blotting: Protein-level validation of silencing effects.
Flow cytometry: Cell-based analysis for functional impacts.
Microarray analysis: Alternative to NGS for expression profiling.
Nanopore sequencing: Long-read technology for comprehensive coverage.
Single-cell sequencing: Resolving off-target effects at individual cell level.
ChIP-seq: Assessing epigenetic changes related to silencing.
Proteomics approaches: Evaluating protein expression and interactions.